<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05002829</url>
  </required_header>
  <id_info>
    <org_study_id>20191238</org_study_id>
    <nct_id>NCT05002829</nct_id>
  </id_info>
  <brief_title>Restricted or Liberal Antibiotics After Appendectomy</brief_title>
  <official_title>Complicated And Simple Appendicitis: Restrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX) Using Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR): A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if decreasing the amount of antibiotics after&#xD;
      appendicitis surgery can decrease the risk of adverse effects associated with antibiotics&#xD;
      while at the same time ensuring participant safety.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">July 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with no antibiotic related adverse effects</measure>
    <time_frame>Up to 40 days after appendicitis surgery</time_frame>
    <description>As assessed by treating physician</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Infectious/Antibiotic Complications</measure>
    <time_frame>Up to 40 days after appendicitis surgery</time_frame>
    <description>Infectious/antibiotic complication requiring antibiotic treatment only, Emergency Department visit, hospital readmission, percutaneous drainage, and operative intervention as assessed by treating physician.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participant deaths</measure>
    <time_frame>Up to 40 days after appendicitis surgery</time_frame>
    <description>As assessed by treating physician</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2275</enrollment>
  <condition>Appendicitis</condition>
  <arm_group>
    <arm_group_label>Restricted Post-Operative Antibiotics Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants undergoing standard of care (SOC) with simple appendicitis will not receive post-operative antibiotics.&#xD;
Participants undergoing standard of care with complicated (gangrenous or perforated) appendicitis will receive up to 24 hours of SOC post-operative antibiotics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liberal Post-Operative Antibiotics Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants undergoing standard of care with simple appendicitis will receive 24 hours of post-operative SOC antibiotics&#xD;
Participants undergoing standard of care with complicated (gangrenous or perforated) appendicitis will receive 4 days of post-operative SOC antibiotics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Restricted Duration of SOC Antibiotic Use</intervention_name>
    <description>Standard of Care Antibiotic use will be restricted to none or up to 24 hours of post-operative antibiotics.</description>
    <arm_group_label>Restricted Post-Operative Antibiotics Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liberal Duration of SOC Antibiotic Use</intervention_name>
    <description>Standard of Care Antibiotic use will be permitted for 24 hours or up to 4 days of post-operative antibiotics.</description>
    <arm_group_label>Liberal Post-Operative Antibiotics Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
          -  Planned appendectomy (laparoscopic or open)&#xD;
&#xD;
          -  Willing and able to provide informed consent&#xD;
&#xD;
          -  Working telephone number or reliable method to contact patient after hospital&#xD;
             discharge&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to consent&#xD;
&#xD;
          -  Pregnant Women&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Immunocompromised&#xD;
&#xD;
          -  Unlikely to comply with treatment or follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel D Yeh, MD, MHPE</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami / Ryder Trauma Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel D Yeh, MD, MHPE</last_name>
    <phone>1-305-585-1822</phone>
    <email>dxy154@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>D. Dante Yeh, MD</last_name>
      <phone>305-585-1178</phone>
      <email>dxy154@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>D. Dante Yeh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, Evans HL, Cook CH, O'Neill PJ, Mazuski JE, Askari R, Wilson MA, Napolitano LM, Namias N, Miller PR, Dellinger EP, Watson CM, Coimbra R, Dent DL, Lowry SF, Cocanour CS, West MA, Banton KL, Cheadle WG, Lipsett PA, Guidry CA, Popovsky K; STOP-IT Trial Investigators. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015 May 21;372(21):1996-2005. doi: 10.1056/NEJMoa1411162. Erratum in: N Engl J Med. 2018 Jan 25;:null.</citation>
    <PMID>25992746</PMID>
  </reference>
  <reference>
    <citation>Yeh DD, Eid AI, Young KA, Wild J, Kaafarani HMA, Ray-Zack M, Kana'an T, Lawless R, Cralley AL, Crandall M; EAST Appendicitis Study Group. Multicenter Study of the Treatment of Appendicitis in America: Acute, Perforated, and Gangrenous (MUSTANG), an EAST Multicenter Study. Ann Surg. 2021 Mar 1;273(3):548-556. doi: 10.1097/SLA.0000000000003661.</citation>
    <PMID>31663966</PMID>
  </reference>
  <reference>
    <citation>Lawless RA, Cralley A, Qian S, Vasileiou G, Yeh DD; EAST Appendicitis Study Group. Antibiotics after Simple (Acute) Appendicitis are not Associated with Better Clinical Outcomes: A Post-Hoc Analysis of an EAST Multi-Center Study. Surg Infect (Larchmt). 2021 Jun;22(5):504-508. doi: 10.1089/sur.2019.348. Epub 2020 Sep 3.</citation>
    <PMID>32897168</PMID>
  </reference>
  <reference>
    <citation>Bou Zein Eddine S, Dodgion CM, Qian S, Trevino C, De Moya MA, Yeh DD; EAST Appendicitis Research Group. Complicated Appendicitis: Are Extended Antibiotics Necessary? A Post Hoc Analysis of the EAST Appendicitis &quot;MUSTANG&quot; Study. J Surg Res. 2020 Mar;247:508-513. doi: 10.1016/j.jss.2019.09.054. Epub 2019 Dec 4.</citation>
    <PMID>31812337</PMID>
  </reference>
  <reference>
    <citation>Evans SR, Rubin D, Follmann D, Pennello G, Huskins WC, Powers JH, Schoenfeld D, Chuang-Stein C, Cosgrove SE, Fowler VG Jr, Lautenbach E, Chambers HF. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR). Clin Infect Dis. 2015 Sep 1;61(5):800-6. doi: 10.1093/cid/civ495. Epub 2015 Jun 25.</citation>
    <PMID>26113652</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 4, 2021</study_first_submitted>
  <study_first_submitted_qc>August 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2021</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Daniel Dante Yeh</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>post-operative</keyword>
  <keyword>antibiotics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

